Vault-13

683 Capital Management, LLC

NEW YORK, NY · CIK 1404574 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2012 · limited liability company

$1.1bn reported value +0.9% vs Q1 2026
128positions
39.1%in top 10
19 new 28 added 38 reduced 99 sold out vs Q1 2026

Options: 3 call positions ($19.4m notional), 22 put positions ($929.6m notional) – listed below, not included above.

This report includes the holdings of 1 other manager that shares the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CAPITAL ONE FINL CORP COM COF COF 365,000 $73.2m6.73% 6.73% ReducedShares held: Q3 2025 325.0k, Q4 2025 335.0k, Q1 2026 375.0k, Q2 2026 365.0k -10.0k -10,000 -2.7%
2 CARVANA CO CL A CVNA CVNA 750,000 $49.4m4.54% 4.54% ReducedShares held: Q3 2025 750.0k, Q4 2025 750.0k, Q1 2026 775.0k, Q2 2026 750.0k -25.0k -25,000 -3.2%
3 ANAPTYSBIO INC COM ANAB ANAB 660,000 $44.6m4.10% 4.10% AddedShares held: Q3 2025 547.0k, Q4 2025 648.1k, Q1 2026 625.0k, Q2 2026 660.0k +35.0k +35,000 5.6%
4 KASPI KZ JSC SPONSORED ADS KSPI KSPI 470,000 $40.7m3.74% 3.74% ReducedShares held: Q3 2025 0, Q4 2025 265.0k, Q1 2026 475.0k, Q2 2026 470.0k -5.0k -5,000 -1.1%
5 BRIDGEBIO PHARMA INC NOTE 2.500% 3/1 · principal BBIO 2.5 03.15.27 · principal BBIO 2.5 03.15.27 21,750,000 $38.8m3.57% 3.57% UnchangedPrincipal held: Q3 2025 21.8m, Q4 2025 21.8m, Q1 2026 21.8m, Q2 2026 21.8m
6 BECTON DICKINSON & CO COM BDX BDX 250,000 $37.8m3.48% 3.48% AddedShares held: Q3 2025 0, Q4 2025 90.0k, Q1 2026 225.0k, Q2 2026 250.0k +25.0k +25,000 11.1%
7 MOLINA HEALTHCARE INC COM MOH MOH 165,000 $37.7m3.47% 3.47% AddedShares held: Q3 2025 81.0k, Q4 2025 135.0k, Q1 2026 160.0k, Q2 2026 165.0k +5.0k +5,000 3.1%
8 HILTON GRAND VACATIONS INC COM HGV HGV 690,000 $36.1m3.32% 3.32% ReducedShares held: Q3 2025 625.0k, Q4 2025 745.0k, Q1 2026 775.0k, Q2 2026 690.0k -85.0k -85,000 -11.0%
9 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 290,000 $35.5m3.27% 3.27% ReducedShares held: Q3 2025 407.5k, Q4 2025 380.7k, Q1 2026 355.0k, Q2 2026 290.0k -65.0k -65,000 -18.3%
10 MEIRAGTX HLDGS PLC COM MGTX MGTX 2,300,000 $31.1m2.86% 2.86% ReducedShares held: Q3 2025 2.6m, Q4 2025 2.6m, Q1 2026 2.5m, Q2 2026 2.3m -150.0k -150,000 -6.1%
11 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,950,000 $28.8m2.64% 2.64% AddedShares held: Q3 2025 4.2m, Q4 2025 4.0m, Q1 2026 4.9m, Q2 2026 5.0m +50.0k +50,000 1.0%
12 UNIQURE NV SHS QURE QURE 575,000 $26.5m2.44% 2.44% AddedShares held: Q3 2025 1.1m, Q4 2025 384.9k, Q1 2026 500.0k, Q2 2026 575.0k +75.0k +75,000 15.0%
13 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 1,279,512 $23.0m2.11% 2.11% ReducedShares held: Q3 2025 1.8m, Q4 2025 1.6m, Q1 2026 1.5m, Q2 2026 1.3m -250.5k -250,488 -16.4%
14 AMENTUM HOLDINGS INC COM AMTM AMTM 1,100,000 $22.7m2.09% 2.09% AddedShares held: Q3 2025 1.3m, Q4 2025 835.0k, Q1 2026 775.0k, Q2 2026 1.1m +325.0k +325,000 41.9%
15 TG THERAPEUTICS INC COM TGTX TGTX 389,081 $21.4m1.97% 1.97% ReducedShares held: Q3 2025 325.0k, Q4 2025 360.0k, Q1 2026 590.0k, Q2 2026 389.1k -200.9k -200,919 -34.0%
16 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,850,000 $20.1m1.85% 1.85% UnchangedShares held: Q3 2025 1.8m, Q4 2025 1.8m, Q1 2026 1.9m, Q2 2026 1.9m
17 UNITY SOFTWARE INC COM U U 615,000 $17.6m1.62% 1.62% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 615.0k
18 WESTERN ALLIANCE BANCORP COM WAL WAL 200,000 $16.4m1.51% 1.51% ReducedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 225.0k, Q2 2026 200.0k -25.0k -25,000 -11.1%
19 IAMGOLD CORP COM IAG IAG 1,010,000 $16.0m1.47% 1.47% ReducedShares held: Q3 2025 900.0k, Q4 2025 900.0k, Q1 2026 1.1m, Q2 2026 1.0m -40.0k -40,000 -3.8%
20 ELEVANCE HEALTH INC COM ELV ELV 40,000 $15.5m1.42% 1.42% UnchangedShares held: Q3 2025 18.0k, Q4 2025 42.0k, Q1 2026 40.0k, Q2 2026 40.0k
21 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 750,000 $15.1m1.39% 1.39% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 750.0k
22 KNOT OFFSHORE PARTNERS LP COM UNITS KNOP KNOP 1,505,000 $15.0m1.38% 1.38% AddedShares held: Q3 2025 1.5m, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.5m +25.0k +25,000 1.7%
23 SAREPTA THERAPEUTICS INC COM SRPT SRPT 782,500 $14.1m1.29% 1.29% AddedShares held: Q3 2025 990.0k, Q4 2025 810.0k, Q1 2026 750.0k, Q2 2026 782.5k +32.5k +32,500 4.3%
24 UNITEDHEALTH GROUP INC COM UNH UNH 32,000 $13.3m1.22% 1.22% UnchangedShares held: Q3 2025 48.0k, Q4 2025 45.0k, Q1 2026 32.0k, Q2 2026 32.0k
25 SEA LTD SPONSORD ADS SE SE 135,000 $12.9m1.19% 1.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 135.0k
26 ALPHABET INC CAP STK CL A GOOGL GOOGL 35,000 $12.5m1.15% 1.15% ReducedShares held: Q3 2025 36.0k, Q4 2025 36.0k, Q1 2026 36.0k, Q2 2026 35.0k -1.0k -1,000 -2.8%
27 ZEVRA THERAPEUTICS INC COM NEW ZVRA ZVRA 855,000 $12.3m1.13% 1.13% ReducedShares held: Q3 2025 975.0k, Q4 2025 905.0k, Q1 2026 975.0k, Q2 2026 855.0k -120.0k -120,000 -12.3%
28 GENUINE PARTS CO COM GPC GPC 101,000 $11.9m1.10% 1.10% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 105.0k, Q2 2026 101.0k -4.0k -4,000 -3.8%
29 ARIS MNG CORP COM ARIS ARIS 770,000 $11.5m1.06% 1.06% ReducedShares held: Q3 2025 900.0k, Q4 2025 900.0k, Q1 2026 800.0k, Q2 2026 770.0k -30.0k -30,000 -3.8%
30 INFLARX NV COM IFRX IFRX 5,065,000 $11.3m1.04% 1.04% AddedShares held: Q3 2025 2.2m, Q4 2025 3.3m, Q1 2026 3.3m, Q2 2026 5.1m +1.8m +1,750,000 52.8%
31 COUPANG INC CL A CPNG CPNG 650,000 $11.3m1.04% 1.04% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 610.0k, Q2 2026 650.0k +40.0k +40,000 6.6%
32 GXO LOGISTICS INCORPORATED COMMON STOCK GXO GXO 215,000 $10.9m1.00% 1.00% ReducedShares held: Q3 2025 775.0k, Q4 2025 685.0k, Q1 2026 500.0k, Q2 2026 215.0k -285.0k -285,000 -57.0%
33 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 294,000 $10.7m0.98% 0.98% NewShares held: Q3 2025 282.0k, Q4 2025 415.0k, Q1 2026 0, Q2 2026 294.0k
34 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 35,000 $10.5m0.97% 0.97% AddedShares held: Q3 2025 0, Q4 2025 3.8k, Q1 2026 21.0k, Q2 2026 35.0k +14.0k +14,000 66.7%
35 NU HLDGS LTD ORD SHS CL A NU NU 750,000 $10.0m0.92% 0.92% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 750.0k
36 HOWARD HUGHES HOLDINGS INC COM HHH HHH 140,000 $10.0m0.92% 0.92% AddedShares held: Q3 2025 38.0k, Q4 2025 38.0k, Q1 2026 35.5k, Q2 2026 140.0k +104.5k +104,500 294.4%
37 ASTRANA HEALTH INC COM NEW ASTH ASTH 210,000 $9.7m0.90% 0.90% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 700.0k, Q2 2026 210.0k -490.0k -490,000 -70.0%
38 ENOVA INTL INC COM ENVA ENVA 40,000 $9.6m0.89% 0.89% UnchangedShares held: Q3 2025 0, Q4 2025 30.0k, Q1 2026 40.0k, Q2 2026 40.0k
39 SEADRILL LTD COM SDRL SDRL 240,000 $9.1m0.83% 0.83% ReducedShares held: Q3 2025 200.0k, Q4 2025 200.0k, Q1 2026 250.0k, Q2 2026 240.0k -10.0k -10,000 -4.0%
40 LENNAR CORP CL A LEN LEN 100,000 $9.0m0.83% 0.83% AddedShares held: Q3 2025 79.0k, Q4 2025 65.5k, Q1 2026 5.0k, Q2 2026 100.0k +95.0k +95,000 1900.0%
41 BARRICK MNG CORP COM SHS B B 242,000 $8.9m0.82% 0.82% ReducedShares held: Q3 2025 750.0k, Q4 2025 400.0k, Q1 2026 400.0k, Q2 2026 242.0k -158.0k -158,000 -39.5%
42 LEXEO THERAPEUTICS INC COM LXEO LXEO 1,875,000 $8.7m0.80% 0.80% AddedShares held: Q3 2025 922.7k, Q4 2025 1.1m, Q1 2026 1.2m, Q2 2026 1.9m +675.0k +675,000 56.2%
43 BRISTOW GROUP INC COM VTOL VTOL 205,000 $8.5m0.78% 0.78% AddedShares held: Q3 2025 175.3k, Q4 2025 186.0k, Q1 2026 186.0k, Q2 2026 205.0k +19.0k +19,000 10.2%
44 ICON PLC SHS ICLR ICLR 48,000 $8.3m0.77% 0.77% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 62.0k, Q2 2026 48.0k -14.0k -14,000 -22.6%
45 BUILDERS FIRSTSOURCE INC COM BLDR BLDR 90,000 $8.1m0.74% 0.74% AddedShares held: Q3 2025 36.0k, Q4 2025 36.0k, Q1 2026 80.0k, Q2 2026 90.0k +10.0k +10,000 12.5%
46 SHATTUCK LABS INC COM STTK STTK 1,157,216 $8.0m0.74% 0.74% AddedShares held: Q3 2025 1.5m, Q4 2025 1.4m, Q1 2026 800.0k, Q2 2026 1.2m +357.2k +357,216 44.6%
47 ANTERIX INC COM ATEX ATEX 66,000 $6.8m0.62% 0.62% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 46.0k, Q2 2026 66.0k +20.0k +20,000 43.5%
48 CARTESIAN THERAPEUTICS INC COM NEW RNAC RNAC 650,000 $6.8m0.62% 0.62% AddedShares held: Q3 2025 230.0k, Q4 2025 280.0k, Q1 2026 330.0k, Q2 2026 650.0k +320.0k +320,000 97.0%
49 NOBLE CORP PLC ORD SHS A NE NE 175,000 $6.5m0.60% 0.60% AddedShares held: Q3 2025 128.0k, Q4 2025 32.5k, Q1 2026 150.0k, Q2 2026 175.0k +25.0k +25,000 16.7%
50 GOSSAMER BIO INC COM GOSS GOSS 39,198,868 $6.5m0.59% 0.59% AddedShares held: Q3 2025 5.1m, Q4 2025 5.2m, Q1 2026 5.0m, Q2 2026 39.2m +34.2m +34,198,868 684.0%
51 ALECTOR INC COM ALEC ALEC 3,200,000 $6.4m0.59% 0.59% UnchangedShares held: Q3 2025 1.0m, Q4 2025 3.4m, Q1 2026 3.2m, Q2 2026 3.2m
52 DOUBLEDOWN INTERACTIVE CO LT ADS DDI DDI 550,000 $6.3m0.58% 0.58% AddedShares held: Q3 2025 300.0k, Q4 2025 500.0k, Q1 2026 514.7k, Q2 2026 550.0k +35.3k +35,344 6.9%
53 APARTMENT INVT & MGMT CO CL A AIV AIV 2,100,000 $6.2m0.57% 0.57% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.4m, Q2 2026 2.1m +650.0k +650,000 44.8%
54 CARDLYTICS INC NOTE 4.250% 4/0 · principal CDLX 4.25 04.01.29 · principal CDLX 4.25 04.01.29 20,500,000 $5.9m0.54% 0.54% AddedPrincipal held: Q3 2025 15.0m, Q4 2025 15.0m, Q1 2026 15.5m, Q2 2026 20.5m +5.0m +5,000,000 32.3%
55 MOODYS CORP COM MCO MCO 11,000 $5.0m0.46% 0.46% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 11.0k, Q2 2026 11.0k
56 S&P GLOBAL INC COM SPGI SPGI 12,087 $4.9m0.45% 0.45% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 12.1k, Q2 2026 12.1k
57 ENERGY RECOVERY INC COM ERII ERII 530,000 $4.8m0.44% 0.44% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 550.0k, Q2 2026 530.0k -20.0k -20,000 -3.6%
58 AMAZON COM INC COM AMZN AMZN 19,000 $4.5m0.42% 0.42% ReducedShares held: Q3 2025 26.5k, Q4 2025 26.5k, Q1 2026 26.5k, Q2 2026 19.0k -7.5k -7,500 -28.3%
59 BARNES & NOBLE ED INC COM NEW BNED BNED 349,046 $4.4m0.40% 0.40% ReducedShares held: Q3 2025 350.0k, Q4 2025 350.0k, Q1 2026 380.0k, Q2 2026 349.0k -31.0k -30,954 -8.2%
60 ATRIUM THERAPEUTICS INC COM RNA RNA 300,000 $4.0m0.37% 0.37% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 300.0k, Q2 2026 300.0k
61 WW INTL INC COM NEW WW WW 242,017 $3.9m0.36% 0.36% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 150.0k, Q2 2026 242.0k +92.0k +92,017 61.3%
62 SPACE ASSET ACQUISITION CORP USD CL A ORD SHS SAAQ SAAQ 375,000 $3.8m0.35% 0.35% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 375.0k, Q2 2026 375.0k
63 HYPERLIQUID STRATEGIES INC COM PURR PURR 480,000 $3.8m0.35% 0.35% ReducedShares held: Q3 2025 0, Q4 2025 1.6m, Q1 2026 850.0k, Q2 2026 480.0k -370.0k -370,000 -43.5%
64 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 11,777,856 $3.7m0.34% 0.34% ReducedShares held: Q3 2025 4.9m, Q4 2025 15.0m, Q1 2026 12.0m, Q2 2026 11.8m -222.1k -222,144 -1.9%
65 MAGNUM ICE CREAM CO NV ORD SHS MICC MICC 201,000 $3.5m0.32% 0.32% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 201.0k
66 INSPIRED ENTMT INC COM INSE INSE 423,580 $3.5m0.32% 0.32% ReducedShares held: Q3 2025 1.1m, Q4 2025 1.1m, Q1 2026 1.0m, Q2 2026 423.6k -624.9k -624,916 -59.6%
67 SILVERCORP METALS INC COM SVM SVM 333,400 $3.4m0.31% 0.31% ReducedShares held: Q3 2025 325.0k, Q4 2025 200.0k, Q1 2026 406.0k, Q2 2026 333.4k -72.6k -72,600 -17.9%
68 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 1,450,000 $3.1m0.28% 0.28% ReducedShares held: Q3 2025 820.0k, Q4 2025 1.5m, Q1 2026 1.5m, Q2 2026 1.4m -50.0k -50,000 -3.3%
69 CONNECT BIOPHARMA HLDGS LTD SHS CNTB CNTB 1,285,000 $3.1m0.28% 0.28% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 900.0k, Q2 2026 1.3m +385.0k +385,000 42.8%
70 PAN AMERN SILVER CORP COM PAAS PAAS 67,000 $3.0m0.28% 0.28% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 100.0k, Q2 2026 67.0k -33.0k -33,000 -33.0%
71 HYLIION HOLDINGS CORP COMMON STOCK HYLN HYLN 575,000 $3.0m0.28% 0.28% ReducedShares held: Q3 2025 825.0k, Q4 2025 825.0k, Q1 2026 725.0k, Q2 2026 575.0k -150.0k -150,000 -20.7%
72 NAVIGATOR HLDGS LTD SHS NVGS NVGS 140,000 $2.6m0.24% 0.24% ReducedShares held: Q3 2025 180.0k, Q4 2025 186.0k, Q1 2026 186.0k, Q2 2026 140.0k -46.0k -46,000 -24.7%
73 PROQR THRAPEUTICS N V SHS EURO PRQR PRQR 1,393,067 $2.6m0.24% 0.24% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.4m
74 LAFAYETTE ACQUISITION CORP ORD SHS LAFA LAFA 250,000 $2.5m0.23% 0.23% UnchangedShares held: Q3 2025 0, Q4 2025 250.0k, Q1 2026 250.0k, Q2 2026 250.0k
75 ACP HOLDINGS ACQUISITION COR CL A ACGC ACGC 250,000 $2.5m0.23% 0.23% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 250.0k
76 IMMUNIC INC COM NEW IMUX IMUX 147,245 $2.3m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 147.2k
77 INVIVYD INC COM IVVD IVVD 2,482,543 $2.2m0.20% 0.20% ReducedShares held: Q3 2025 6.3m, Q4 2025 2.9m, Q1 2026 2.5m, Q2 2026 2.5m -32.5k -32,457 -1.3%
78 INSMED INC COM PAR $.01 INSM INSM 20,000 $2.1m0.20% 0.20% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
79 OCTAVE INTELLIGENCE PLC ORD SHS CL B OCTV OCTV 125,000 $2.0m0.19% 0.19% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 125.0k
80 CHENGHE ACQUISITION III CO ORD SHS CL A CHEC CHEC 200,000 $2.0m0.19% 0.19% UnchangedShares held: Q3 2025 0, Q4 2025 200.0k, Q1 2026 200.0k, Q2 2026 200.0k
81 ARCHIMEDES TECH SPAC PTNRS I ORD SHS ARCI ARCI 200,000 $2.0m0.18% 0.18% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 200.0k
82 FG IMPERII ACQUISITION CORP ORD SHS CL A FGII FGII 200,000 $2.0m0.18% 0.18% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 200.0k
83 LEGATO MERGER CORP IV ORD SHS LEGO LEGO 200,000 $2.0m0.18% 0.18% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 200.0k, Q2 2026 200.0k
84 PANGAEA LOGISTICS SOLUTION L SHS PANL PANL 300,000 $1.9m0.18% 0.18% ReducedShares held: Q3 2025 535.0k, Q4 2025 495.0k, Q1 2026 309.5k, Q2 2026 300.0k -9.5k -9,500 -3.1%
85 COINBASE GLOBAL INC COM CL A COIN COIN 13,000 $1.9m0.17% 0.17% NewShares held: Q3 2025 3.0k, Q4 2025 15.7k, Q1 2026 0, Q2 2026 13.0k
86 AMRIZE LTD SHS AMRZ AMRZ 35,000 $1.9m0.17% 0.17% UnchangedShares held: Q3 2025 35.0k, Q4 2025 35.0k, Q1 2026 35.0k, Q2 2026 35.0k
87 HUDSON TECHNOLOGIES INC COM HDSN HDSN 325,000 $1.9m0.17% 0.17% UnchangedShares held: Q3 2025 350.0k, Q4 2025 335.0k, Q1 2026 325.0k, Q2 2026 325.0k
88 SATELLOS BIOSCIENCE INC COM MSLE MSLE 230,833 $1.8m0.17% 0.17% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 230.8k, Q2 2026 230.8k
89 BRIDGEBIO PHARMA INC NOTE 1.750% 3/0 · principal BBIO 1.75 03.01.31 · principal BBIO 1.75 03.01.31 1,000,000 $1.7m0.15% 0.15% UnchangedPrincipal held: Q3 2025 0, Q4 2025 0, Q1 2026 1.0m, Q2 2026 1.0m
90 BLUE WTR ACQUISITION CORP. I ORD SHS CL A BLUW BLUW 150,000 $1.5m0.14% 0.14% UnchangedShares held: Q3 2025 150.0k, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
91 MAIA BIOTECHNOLOGY INC COM MAIA MAIA 1,066,666 $1.5m0.14% 0.14% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.1m, Q2 2026 1.1m
92 EQV VENTURES AC CORP. II ORD SHS CL A EVAC EVAC 150,000 $1.5m0.14% 0.14% UnchangedShares held: Q3 2025 150.0k, Q4 2025 150.0k, Q1 2026 150.0k, Q2 2026 150.0k
93 D MARKET ELECTR SVCS & TRADI SPONSORED ADS HEPS HEPS 500,000 $1.5m0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 500.0k
94 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 459,367 $1.4m0.13% 0.13% ReducedShares held: Q3 2025 525.0k, Q4 2025 891.9k, Q1 2026 896.3k, Q2 2026 459.4k -436.9k -436,896 -48.8%
95 WILLOW LANE ACQUISITION CRP USD CL A ORD SHS WLII WLII 125,000 $1.3m0.12% 0.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 125.0k
96 PROMIS NEUROSCIENCES INC COM SHS PMN PMN 95,000 $1.3m0.11% 0.11% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 92.8k, Q2 2026 95.0k +2.1k +2,150 2.3%
97 LIGHTWAVE ACQUISITION CORP USD CL A ORD SHS LWAC LWAC 100,000 $1.0m0.09% 0.09% UnchangedShares held: Q3 2025 100.0k, Q4 2025 100.0k, Q1 2026 100.0k, Q2 2026 100.0k
98 IN8BIO INC COM NEW INAB INAB 724,637 $1.0m0.09% 0.09% UnchangedShares held: Q3 2025 0, Q4 2025 724.6k, Q1 2026 724.6k, Q2 2026 724.6k
99 CARDLYTICS INC COM NEW CDLX CDLX 200,000 $898.0k0.08% 0.08% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 200.0k
100 OYSTER ENTERPRISES II ACQUIS ORD SHS CL A OYSE OYSE 75,000 $771.8k0.07% 0.07% UnchangedShares held: Q3 2025 75.0k, Q4 2025 75.0k, Q1 2026 75.0k, Q2 2026 75.0k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ELI LILLY & CO LLY LLY 15,000 $13.8m15.0k shares
AMICUS THERAPEUTICS INC FOLD FOLD 775,000 $11.2m775.0k shares
GOSSAMER BIO INC GOSS 5 06.01.27 GOSS 5 06.01.27 27,877,000 $10.6m27.9m shares
APELLIS PHARMACEUTICALS INC APLS APLS 250,000 $10.1m250.0k shares
LENNAR CORP LEN.B LEN.B 115,000 $9.7m115.0k shares
BOOKING HOLDINGS INC BKNG BKNG 55,000 $9.3m55.0k shares
COGENT COMMUNICATIONS HLDGS CCOI CCOI 450,300 $8.5m450.3k shares
GLOBALSTAR INC GSAT GSAT 98,000 $6.5m98.0k shares
PERCEPTIVE CAP SOLUTIONS COR FRNM FRNM 561,923 $6.2m561.9k shares
VIKING THERAPEUTICS INC VKTX VKTX 130,000 $4.2m130.0k shares
THERAVANCE BIOPHARMA INC 0TB 0TB 250,000 $4.1m250.0k shares
CAESARS ENTERTAINMENT INC NE CZR CZR 150,000 $4.0m150.0k shares
ABEONA THERAPEUTICS INC ABEO ABEO 770,000 $3.4m770.0k shares
IMMUNIC INC 2,450,000 $2.7m2.5m shares
RXO INC RXO RXO 180,000 $2.6m180.0k shares
NETGEAR INC NTGR NTGR 100,000 $2.2m100.0k shares
CACI INTL INC CACI CACI 4,000 $2.2m4.0k shares
STAGWELL INC STGW STGW 305,000 $1.9m305.0k shares
SCIENCE APPLICATIONS INTL CO SAIC SAIC 19,000 $1.8m19.0k shares
CARDLYTICS INC 1,450,000 $1.5m1.4m shares
ARMATA PHARMACEUTICALS INC ARMP ARMP 137,000 $1.4m137.0k shares
WILLOW LANE ACQUISITION CRP WLIIU WLIIU 125,000 $1.3m125.0k shares
IRSA INVERSIONES Y REP S A IRS IRS 70,000 $1.1m70.0k shares
AMPLIFY ENERGY CORP NEW AMPY AMPY 160,000 $998.4k160.0k shares
AXT INC AXTI AXTI 17,000 $968.7k17.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
PALANTIR TECHNOLOGIES INC PLTR · Put PLTRPut 2,428,700 $283.4m2.4m shares Added
ELI LILLY & CO LLY · Put LLYPut 154,000 $184.7m154.0k shares Added
NVIDIA CORPORATION NVDA · Put NVDAPut 456,000 $91.2m456.0k shares Unchanged
SPDR SER TR XBI · Put XBIPut 540,000 $85.5m540.0k shares New
ABBVIE INC ABBV · Put ABBVPut 245,000 $61.7m245.0k shares New
MADRIGAL PHARMACEUTICALS INC MDGL · Put MDGLPut 90,000 $48.3m90.0k shares Unchanged
PRAXIS PRECISION MEDICINES I PRAX · Put PRAXPut 110,400 $37.0m110.4k shares Reduced
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 107,500 $32.4m107.5k shares Reduced
ARK ETF TR ARKG · Put ARKGPut 750,000 $31.5m750.0k shares Added
IONQ INC IONQ · Put IONQPut 486,700 $25.9m486.7k shares Reduced
UNIQURE NV QURE · Call QURECall 316,200 $14.6m316.2k shares Reduced
MODERNA INC MRNA · Put MRNAPut 156,000 $10.9m156.0k shares Unchanged
LENNAR CORP LEN · Put LENPut 100,000 $9.0m100.0k shares Reduced
HIMS & HERS HEALTH INC HIMS · Put HIMSPut 220,000 $7.6m220.0k shares Unchanged
INSMED INC INSM · Put INSMPut 35,000 $3.7m35.0k shares Reduced
KYMERA THERAPEUTICS INC KYMR · Put KYMRPut 30,000 $3.4m30.0k shares New
VIKING THERAPEUTICS INC VKTX · Call VKTXCall 80,000 $3.1m80.0k shares Added
IOVANCE BIOTHERAPEUTICS INC IOVA · Put IOVAPut 644,300 $2.7m644.3k shares Unchanged
COINBASE GLOBAL INC COIN · Put COINPut 17,000 $2.5m17.0k shares Unchanged
NOVO-NORDISK A S NVO · Put NVOPut 50,000 $2.4m50.0k shares Reduced
MICROSTRATEGY INC MSTR · Put MSTRPut 25,000 $2.2m25.0k shares Reduced
AMYLYX PHARMACEUTICALS INC AMLX · Call AMLXCall 96,600 $1.7m96.6k shares Unchanged
ULTRAGENYX PHARMACEUTICAL IN RARE · Put RAREPut 50,000 $1.7m50.0k shares New
TRANSMEDICS GROUP INC TMDX · Put TMDXPut 20,000 $1.3m20.0k shares Unchanged
HARMONY BIOSCIENCES HLDGS IN HRMY · Put HRMYPut 14,700 $535.2k14.7k shares Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
GOSSAMER BIO INC GOSS · 13G · filed 2026-06-11 GOSS 10.0%≈ $8.2m +6.1 pts 13G 2026-06-11
MEREO BIOPHARMA GROUP PLC MREO · 13G · filed 2026-01-06 MREO 8.2% new 13G 2026-01-06
IN8BIO INC INAB · 13G · filed 2025-12-30 INAB 7.9%≈ $1.1m new 13G 2025-12-30
IMMUNIC INC 13G · filed 2026-02-17 5.9% -4.0 pts 13G 2026-02-17